Member Info for JustHereForHemo

Cash is king and this has further to go so definitely not advising anyone to sell now.
However I recommend slicing and taking profits WHEN THE TIME IS RIGHT FOR YOU.
And it may be a little cheaky to drop in here and suggest but may I recommend the following for considering if you plan to diversify :
Pineapple Power PNPL just listed today so ground floor entry for what is expected to be a very fast acquisition of a renewable energy company.
Hemogenyx HEMO are about to make big waves in cancer treatments in 2021 and possibly have a Covid-19 cure which could be revolutionary!

Anyway, again good luck here, fantastic NEWS!

Merry Christmas share holders!

If pumpkin lays off here I don't care if reat goes to 200p
Mms printed a ut of 8.4 for 100 shares, looks like they want shares, busy day though so won't be watching, have a merry Christmas everyone, kids are awake and hyper!

Whilst I have been very open and critical of various actions here recently and the risk of a placing given the directors small spaced out buys, the warrants pricing etc it is possible that its for a good reason. Perhaps there is a placing due? Perhaps the directors do want to raise the SP to reduce dilution but if they want to fund raise for an acquisition then that is not something to fear. A placing RNS which details that the money is to be used to take over a distressed smaller company with a big customer base or a supplier in distress would be a positive driver on the SP.
Likewise, its possible that maybe the Directors do actually believe in the company and the small amounts where just what they had to hand?

Bottom line is Reat is probably unlikely to go bust, they are a small cleaning company and will always be able to find work/contracts. They have plenty of cash in the bank to keep the lights on and there are plenty of companies out there in serious distress right now that are ripe for take over. If I was a director here I would be looking at contract cleaners for the hospitality industry, there are companies that only clean for hotels and that business is decimated right now but will bounce back eventually, or think bigger, caravan and leisure parks, there is alot more overlap there than you might imagine if the company is willing to think outside the box. (Pumpkin sorry but MUST is a total dog, I cant support your investment there)
Anyway, I am totally committed elsewhere and Reat is not in an industry that I ever invest in, but I wish everyone here the best. At such a small MCap there is no reason why it should not bag given the right sort of deal or take over, its a gamble of course but whats not?

Unless Pumpkin goes bonkers again I wont be back so Merry Christmas, Happy new Year, happy Easter etc.....

Merry Christmas to you too Bullish, and I am 100% in agreement, I personally never used to post on a thread I was not invested in or planning to invest in, its just a complete and utter waste of time. Never wanted too or intended to post here but I have to be honest, by and large it has worked and Pumpkin has mostly wound her neck in, before we started posting here she was really out of control. If she stays in her box I am certainly happy to be supportive here, I am even capable of posting the positive views of Reat if she does such as...

Bullish, believe me none of us negative or realistic posters WANT to post here, it's just very easy to call out the problems here. If pumpkin would grow up and stop being a total idiot people would stop retaliating, just sick of her. As for Reat, the rail contract expires in a month, I'll let people decide the likely hood of renewal, if its renewed then trade sideways if not......
See they made back some of yesterday's losses, well done, id love nothing more to leave everyone here to make a decent profit and if pumpkin decides to turn over a new leaf then there will be lots of quiet days, personally though I didn't post today because I was busy shopping all day!

@Starfox- exactly, the extension date was set AFTER work started in the lab to select the best antibody, it would seem pretty idiotic to not give themselves plenty of breathing space in that extension to complete the work, they would have known the timespan required before blood draw and then some time for lab work and finally putting that together for analysis, I think from that youtube video the dosing and waiting period was 3-5 weeks so 31st December would have been ample time.

Question will be how much ground work was done on the licencing in all that time when the labs were closed?
IF Eli make an offer or have made an offer and its not good enough will Vlad have to formally reject it, wait for an improved offer or will they all sit around drinking coffee and eating donuts and discuss it in one meeting?
Then if they do come to an agreement how do they licence a certain antibody? is it registered somewhere? does it have some sort of bio signature or DNA that can be registered to Eli? or is it kept as a live specimen somewhere? How do they actually licence the given antibody so that the IP is protected?

For me the RNS for licencing agreement could come tomorrow, or it could take a month, either way I will wait, no way to guess and not worth the risk of being out when it lands.

@Pumpkin, you are an idiot, they are sells as you very rightly know but you wanted to point out someone sold shares in as sly and manipulative way as possible. Its a share, people will buy and people will sell, your little comment adds absolutely nothing of value or interest to anyone positive or negative.
We all understand WHY you want to try and take digs at hemo, your bitter because REAT is down 9.06% and MUST is down 7.84%. You are a failure as an investor and a day trader, by all accounts you seem to be working in B&M just to keep covering your losses from trading. You are spectacuraly good at picking dogs to invest in so believe me when I say I am VERY glad you dont like and are not invested in Hemo, your like Sam, any share you invest in ends up being a dog.
Now please, go and lick your wounds over at REAT and MUST and I for one will not post there again. I actually like some people who are invested in them and would prefer to stop pointing out how bad the companies are for THEIR benifit.

Yep, one of the conditions is an approved prospectus, which has to be approved by the FCA, christmas, lock down etc cant be helping with it either. I am torn between wanting it RIGHT NOW so we can say Hemo is a pharma company and wanting it to take a month or so to allow the SP to bounce up first. Shorter term, IE next 3-6 months Loan now is much better. But longer term like 1-2 years looking at take over the less CLNs in issue the better because although Mint have stated they wont convert or sell them they WILL be considered as full shares when it comes to take over. So at that point an extra 20-30% of hidden but fully entitled shares will get a slice of the takeover pot :P Still going to be billions so its just my greed speaking but this is a once in a lifetime opportunity and I want to make the most out of it!

Think its not a question of confidence in being offered a licensing deal and more a question of being offered a fair deal.
Without this loan offer from Mint Hemogenyx did not have a lot of cash, they did not have enough to fund IND applications or clinical research, they would have needed cash from somewhere be it licencing a product or a placing etc.
PRE-Mint they really were at the mercy of Eli who could have used attrition to delay and low ball knowing Hemo had no alternatives. With the loan that is off the table, Hemo can go with no deal and proceed at pace with CDX.
That said I dont for one second believe that they wont come to an amicable agreement, if they were unlikely to licence they would have walked and kicked Hemo out of their labs long ago. It also opens the door to someone like Pfizer or J&J poaching CDX under their noses after Eli did most of the work... not going to happen.
There is also the fact that the loan was probably months in the making, August or September is my guess, at that time Eli labs were shut to all but Covid, Vlad probably got fed up waiting and started looking for funding for everything then rather than wait for Eli to reopen and make an offer which may then have been a rubbish offer with tiny up front cash after wasting months waiting.

As for the first tranche of the loan, the sooner the better, as soon as they have cash they can file for IND applications straight away and clinical trials can start a very short time later. But please dont get your hopes up, apparently getting a prospectus approved can take quite a while, it has to be approved by the FCA and there can be alot of back and forth, I have been quoted timescales approx 5-6 weeks. After this another week or so to arrange with Mint for the draw down, so honestly whilst it could be late January I realistically dont expect it before February or March, but happy to be wrong and see it sooner.

The only good thing about the waiting for the loan is that there is an excellent chance of the Eli Lilly agreement before the loan gets drawn, if that happens the SP will rocket and any CLNs issued will be at a much inflated SP from today so when Vlad finally decides to sell the company we will all get a bigger share of the pie.

Options have now vested as SP hit 15 following a little pumping and spaced out TR-1s over a few days to drive interest. I was curious about the spike previously to 17 p and wanted to see why, the options explain it. Getting to 15p unlocked them and now for every 1p above vest price of 10p they are sitting on a paper profit of 90k. So if they exercise and sell the warrants now they will still make a decent sum.
If they have burnt through 2/3rds of the cash despite taking zero salary? They must be considering an orderly wind up which would return to share holders what? 3p per share or something? So getting that profit from warrants offsets alot of the losses. If they forward sold when sp was 15p+ they will make a considerable profit.

Good enough for me, when a TR-1 holder starts dumping a cash shell, no need to keep looking. I'm out!
Well I was technically never in but I was curious was there potentially something on offer here, clearly not.

Can someone tell me are there even any rumors of even sniffing at potential targets or is this cash shell going to just close when runs out of cash?
They surely now would need a new cash raising round, but hard to sell a placing without a target in mind otherwise your basically begging for cash and asking people to trust after over a year of nothingness.. Am I wrong? is there ANYTHING here worth investing in?

The previous post is long, the TL;DR version is:
"CDX has been FAST in terms of pharma and delayed only by Covid-19, given the investment of Eli Lilly to date and the competitive advantages they get by licencing before anyone else to not sign a licencing agreement would be crazy"

That post also refers ONLY to CDX with Eli Lilly, Vlad has also been working on other antibodies independently targeting ALL. They have brought HEMO-CAR-T to the point of being ready for clinical trials pending funding.
They have a potential unique cure for Covid-19 without any of the problems with antibodies or vaccines
They have a product to generate bone marrow from a patients own liver cells or umbilical cells removing the need for donors.
They have a humanised mouse model which is in high demand as a clinical precursor and on its own could be sold as a product worth thousands EACH.

Many of the parallel pipelines have been brought as far as they can be in a lab, they have been tested in test tubes and in animals, they work, the next step is human trials, that takes ALOT of cash. Mint have looked at the work and agreed the value add from starting clinical trials is worth offering up 60Mil in cash. They didnt offer say 6mil to take one product line forward. They have offered SIXTY MILLION POUNDS enough to take EVERY pipeline into clinical trials ALONE if necessary. Be under no illusions if all pipelines immediately failed on first human treatment the company would be bust and Mint would lose it all. BUT if ANY single pipeline makes it through clinical trials? the target market is BILLIONS.

The chances are Eli will licence PRE-Clinical CDX
Everything else HOPEFULLY wont be licenced untill its though Phase 1 and 2a trials and we see it working on human patients. At that point the numbers will be eye watering.... There will be delays for sure, but chances of at least one pipeline being pushed ahead early 2021 are pretty good :-)

Start - Vlad develops CDX bi-specific antibodies to eliminate unwanted blood stem cells preparing a patient for bone marrow transplant.
13th March 18 - Begin work with Eli Lilly on CDX as a bone marrow conditioning product in collaboration agreement, initially a 6month project.
14th May 18 - Development Agreement with Eli Lilly "Hemogenyx is developing its lead candidate in readiness for the start of Phase 1 trials." "Under the Agreement, Hemogenyx will grant the global pharmaceutical company a research license for anything jointly developed under the Agreement, as well as an option for an exclusive worldwide license to commercially exploit CDX antibodies or any variants, which will be jointly developed under the Agreement."

Throughout 2018 - Discover that CDX directly targets and kills AML as well as stem cells. IND enabling studies in vitro.
2019 - More positive results, CDX proven to work in vivo and in vitro as bone marrow conditioning and eliminating need for chemo/radio therapy as directly kills AML/ALL

March 2020 - Covid-19 started to have an inpact, Labs were shut and lock downs began. Eli Lilly labs were either shut or redirected to Covid-19, as a result CDX was put on hold.

30th April 2020 - "originally scheduled to complete in late April 2020, is being extended by a short period due to the impact on GlobalCo's operations of the novel coronavirus, following which Hemogenyx will either license the antibody to GlobalCo or will in-license GlobalCo's improvements to it on favourable terms."

2nd June 2020 - Another extension labs are still shut.

27th October 2020 - Further extension LABS ARE OPEN AND HAVE BEGUN WORKING ON CDX. Extension to 31st December 2020 "This additional extension of the collaboration will allow us to choose the best CDX antibody for pre-clinical and clinical development."

Vlad has previously stated that after the Development agreement period Eli have up to 3 months to licence the Antibody on favourable terms after which the option falls back to Hemogenyx.

So whats the point of all this? Basically its unfair to say the company has moved slowly, in 2 years progress has been very fast and in that time the market for CDX has massively as a target for not only BMT but AML/ALL etc as well removing cost/side effects of Chemo/Radio. The target market is Billions per year.
Eli having been there from the start have a significant advantage over competitors and are entitled to a big discount.
Since 2018 they have granted free access to their facilities to Hemogenyx and have agreed to being named. THEY picked 31st December, not Jan, not Feb, not March which they COULD have.

Eli Lilly either Licence CDX from Hemogenyx in the next 3 months or they walk away, given the history and everything I have read I cannot see them walking away. To blame Vlad for the past 9 months delay which was Covid-19 is unfair.

Am I right in saying this is a cash shell with no active acquisition on the cards and was only funded to July 2020 and must now be running on fumes? Added to which the recent results rns states the targets that they WOULD have been targeting have either rejected their bid or no interest in engaging while oil price is down?
Just wondering why people are actually buying any shares here? Seems dead in the water unless anyone can explain the appeal?

Very excited this morning, when vlad is happy I am happy, looking forward to the next stage in Hemogenyx progression.
I left microfocus too soon, didn't follow my instincts and short Duke Mount when I was shouting that it was a pump. Hemo is the one with the unlimited potential. The only one yet to move. They don't need equipment, they don't need to build and test a product that has large overheads, no horizontal scaling costs or timeline delays. They are producing and selling IP, it could be worth 100s of millions or billions and it can arrive any day without notice. No photos of discovery drilling, or hiring of 70 warehouse staff. Its like an on off switch and when this light gets turned on it ain't going off.

Ty :-) I placed a long position the second I saw it so made a few quid today, they might as well put it up in neon letters.

Someone took advantage of this quiet time, they forced the SP down, panicked some PI's into selling and loaded up again making themselves better off in the process. It was always going to go blue today at the end.

In terms of CDX with eli lilly, or HEMO-CAR-T with Penn or finding someone for SAFE-HEMO-CAR-T or J&J with Lupus or a new partner for possibly CBR we really are not in the driving seat here.
With CDX Eli took the option to extend to december to pick the best antibody for them, they potentially may be viewing it in terms of longer term use outside of AML and want to test viability for ALL or just BMT conditioning for a whole range of conditions. I doubt very much if Dr S has any real input on the speed of Eli Lilly.

Hemogenyx is TINY, they have a big product and massive potential but they are not in the driving seat for anything right now until they get the funding which is why with Hemo news is out of the blue and almost always a surprise. If a partner decides its coming up to the end of the year, they have a use or lose budget to spend of x million and time is ticking they could very well decide to make a generous offer to Hemo for a no negotiations licence agreement or up front order for mice.

It will be THEIR BoD that will be making the decisions and calls then when their offer is ready they put it to vlad and either taken or rejected.

Any day could be life changing but its really out of our hands, Eli may have switched off for X-Mas, or maybe they are sitting on a war chest that they either spend or re-distribute to investors as dividends? I really would not write off the chance of news before end of year right now, there is absolutely no guarantee anything will happen but unless you know another sure fire bet to invest in that is the safest bet I have seen.